1.
Ganz J, Luquette LJ, Bizzotto S, et al. Contrasting patterns of somatic mutations in neurons and glia reveal differential predisposition to disease in the aging human brain. bioRxiv : the preprint server for biology. 2023. doi:10.1101/2023.01.14.523958.
1.
Drexler R, Khatri R, Sauvigny T, et al. Epigenetic neural glioblastoma enhances synaptic integration and predicts therapeutic vulnerability. bioRxiv : the preprint server for biology. 2023. doi:10.1101/2023.08.04.552017.
1.
Williams EA, Brastianos PK, Wakimoto H, et al. A comprehensive genomic study of 390 H3F3A-mutant pediatric and adult diffuse high-grade gliomas, CNS WHO grade 4. Acta neuropathologica. 2023. doi:10.1007/s00401-023-02609-6.
1.
Rahme GJ, Javed NM, Puorro KL, et al. Modeling epigenetic lesions that cause gliomas. Cell. 2023. doi:10.1016/j.cell.2023.06.022.
1.
McBrayer SK, Mayers JR, DiNatale GJ, et al. Transaminase Inhibition by 2-Hydroxyglutarate Impairs Glutamate Biosynthesis and Redox Homeostasis in Glioma. Cell. 2018;175(1):101-116.e25. doi:10.1016/j.cell.2018.08.038.
1.
Shankar GM, Kirtane AR, Miller JJ, et al. Genotype-targeted local therapy of glioma. Proc Natl Acad Sci U S A. 2018;115(36):E8388-E8394. doi:10.1073/pnas.1805751115.
1.
Bunse L, Pusch S, Bunse T, et al. Suppression of antitumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarate. Nat Med. 2018;24(8):1192-1203. doi:10.1038/s41591-018-0095-6.
1.
Lin GL, Nagaraja S, Filbin MG, Suvà ML, Vogel H, Monje M. Non-inflammatory tumor microenvironment of diffuse intrinsic pontine glioma. Acta Neuropathol Commun. 2018;6(1):51. doi:10.1186/s40478-018-0553-x.
1.
Filbin MG, Sturm D. Gliomas in Children. Semin Neurol. 2018;38(1):121-130. doi:10.1055/s-0038-1635106.
1.
Griveau A, Seano G, Shelton SJ, et al. A Glial Signature and Wnt7 Signaling Regulate Glioma-Vascular Interactions and Tumor Microenvironment. Cancer Cell. 2018;33(5):874-889.e7. doi:10.1016/j.ccell.2018.03.020.